International Journal of
Reproductive Biomedicine
Sun, Dec 22, 2024
[Archive]
Volume 14, Issue 1 (1-2016)
IJRM 2016, 14(1): 53-56 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Davar R, Miraj S, Farid Mojtahedi1 M. Effect of adding human chorionic gonadotropin to frozen thawed embryo transfer cycles with history of thin endometrium. IJRM 2016; 14 (1) :53-56
URL: http://ijrm.ir/article-1-687-en.html
URL: http://ijrm.ir/article-1-687-en.html
1- Department of Obstetrics and Gynecology, Research and Clinical Center for Infertility, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
2- Shahrekord University of Medical Sciences, Shahrekord, Iran ,dr.s.miraj@gmail.com
2- Shahrekord University of Medical Sciences, Shahrekord, Iran ,
Abstract: (3879 Views)
Background: Embryo implantation process is a complex phenomenon and depends on fetal and maternal factors interaction. Endometrial thickness is needed for successful implantation.
Objective: We designed this study in order to assess adding human chorionic gonadotropin (HCG) to the conventional protocol in endometrial preparation in women with thin endometrium and a history of in vitro fertilization–embryo transfer (IVF-ET) failure.
Materials and Methods: The non-randomized clinical trial study (quasi experimental design) was performed on 28 patients. Participants were women who were candidate for frozen-thawed (ET) and had two previous failed ET cycles because of thin endometrial. HCG was administrated (150 IU, intramuscular) from the 8th day of cycle and when endometrial thickness reached at least 7mm HCG was discontinued and frozen thawed ET was done.
Results: Totally 28 patients were included. The mean ± SD age of participants was 30.39±4.7. The mean of endometrium thickness before and after HCG were 5.07±0.43 and 7.85±0.52, respectively p<0.001. Also, there were five clinically and chemically pregnant women.
Conclusion: The findings of the study suggested that adding HCG to the conventional preparation method was an effective protocol and significantly improved endometrial thickness and pregnancy outcomes in women with previous embryo transfer failure because of thin endometrium.
Objective: We designed this study in order to assess adding human chorionic gonadotropin (HCG) to the conventional protocol in endometrial preparation in women with thin endometrium and a history of in vitro fertilization–embryo transfer (IVF-ET) failure.
Materials and Methods: The non-randomized clinical trial study (quasi experimental design) was performed on 28 patients. Participants were women who were candidate for frozen-thawed (ET) and had two previous failed ET cycles because of thin endometrial. HCG was administrated (150 IU, intramuscular) from the 8th day of cycle and when endometrial thickness reached at least 7mm HCG was discontinued and frozen thawed ET was done.
Results: Totally 28 patients were included. The mean ± SD age of participants was 30.39±4.7. The mean of endometrium thickness before and after HCG were 5.07±0.43 and 7.85±0.52, respectively p<0.001. Also, there were five clinically and chemically pregnant women.
Conclusion: The findings of the study suggested that adding HCG to the conventional preparation method was an effective protocol and significantly improved endometrial thickness and pregnancy outcomes in women with previous embryo transfer failure because of thin endometrium.
Type of Study: Original Article |
References
1. Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update 2006; 12: 685-718. [DOI:10.1093/humupd/dml034]
2. Kunicki M, Lukaszuk K, Woclawek-Potocka I, Liss J, Kulwikowska P, Szczyptańska J. Evaluation of granulocyte colony-stimulating factor effects on treatment-resistant thin endometrium in women undergoing in vitro fertilization. Biomed Res Int 2014; 2014: 913235. [DOI:10.1155/2014/913235]
3. Al-Hasani S. Cancellation of fresh embryo transfer: a future perspective. Int J Fertil Steril 2011; 5: 1-5.
4. Pampfer S, Arceci RJ, Pollard JW. Role of colony stimulating factor-1 (CSF-1) and other lympho-hematopoietic growth factors in mouse pre-implantation development. Bioessays 1991; 13: 535-540. [DOI:10.1002/bies.950131007]
5. Kaye PL, Harvey MB. The role of growth factors in reimplantation development. Prog Growth Factor Res 1995; 6: 1-24. [DOI:10.1016/0955-2235(95)00001-1]
6. Kane MT, Morgan PM, Coonan C. Peptide growth factors and preimplantation development. Hum Reprod Update 1997; 3: 137-157. [DOI:10.1093/humupd/3.2.137]
7. Al-Ghamdi A, Coskun S, Al-Hassan S, Al-Rejjal R, Awartani K. The correlation between endometrial thickness and outcome of in vitro fertilization and embryo transfer (IVF-ET) outcome. Reprod Biol Endocrinol 2008; 6: 37. [DOI:10.1186/1477-7827-6-37]
8. Isaacs Jr, Wells D, Williams R, Odem R, Gast R, Strickler C. Endometrial thickness is a valid monitoringparameter in cycles of ovulation induction with menotropins alone. Fertil Steril 1996; 65: 262-266.
9. Richter KS, Bugge KR, Bromer JG, Levy MJ. Relationship between endometrial thickness and embryo implantation, based on 1,294 cycles of in vitro fertilization with transfer of two blastocyst-stage embryos. Fertil Steril 2007; 87: 53-59. [DOI:10.1016/j.fertnstert.2006.05.064]
10. Kovacs P, Matyas S, Boda K, Kaali SG. The effect of endometrial thickness on IVF/ICSI outcome. Hum Reprod 2003; 18: 2337-2341. [DOI:10.1093/humrep/deg461]
11. Noyes N, Liu HC, Sultan K, Schattman G, Rosenwaks Z. Endometrial thickness appears to be a significant factor in embryo implantation in in-vitro fertilization. Hum Reprod 1995; 10: 919-922. [DOI:10.1093/oxfordjournals.humrep.a136061]
12. Gonen Y, Casper RF, Jacobson W, Blankier J. Endometrial thickness and growth during ovarian stimulation: a possible predictor of implantation in in vitro fertilization. Fertil Steril 1989; 52: 446-450. [DOI:10.1016/S0015-0282(16)60916-0]
13. Traub ML, Van Arsdale A, Pal L, Jindal S, Santoro N. Endometrial thickness, Caucasian ethnicity, and age predict clinical pregnancy following fresh blastocyst embryo transfer: a retrospective cohort. Reprod Biol Endocrinol 2009; 7: 33. [DOI:10.1186/1477-7827-7-33]
14. Check JH, Lurie D, Dietterich C, Callan C, Baker A. Adverse effect of a homogeneous hyperechogenic endometrial sonographic pattern, despite adequate endometrial thickness on pregnancy rates following in-vitro fertilization. Hum Reprod 1993; 8: 1293-1296. [DOI:10.1093/oxfordjournals.humrep.a138244]
15. Jimenez PT, Schon SB, Odem RR, Ratts VS, Jungheim ES. A retrospective cross-sectional study: fresh cycle endometrial thickness is a sensitive predictor of inadequate endometrial thickness in frozen embryo transfer cycles. Reprod Biol Endocrinol 2013; 11: 1-5. [DOI:10.1186/1477-7827-11-35]
16. Chen MJ, Yang JH, Peng FH, Chen SU, Ho HN, Yang YS. Extended Estrogen Administration for Women with Thin Endometrium in Frozen-Thawed in-Vitro Fertilization Programs. J Assist Reprod Genet 2006; 23: 337-342. [DOI:10.1007/s10815-006-9053-1]
17. Weckstein LN, Jacobson A, Galen D, Hampton K, Hammel J. Low-dose aspirin for oocyte donation recipients with a thin endometrium: prospective, randomized study. Fertil Steril 1997; 68: 927-930. [DOI:10.1016/S0015-0282(97)00330-0]
18. Sher G, Fisch JD. Effect of vaginal sildenafil on the outcome of in vitro fertilization (IVF) after multiple IVF failures attributed to poor endometrial development. Fertil Steril 2002; 78: 1073-1076. [DOI:10.1016/S0015-0282(02)03375-7]
19. Ledee-Bataille N, Olivennes F, Lefaix J, Chaouat G, Frydman R, Delanian S. Combined treatment by pentoxifylline and tocopherol for recipient women with a thin endometrium enrolled in an oocyte donation programme. Hum Reprod 2002; 17: 1249-1253. [DOI:10.1093/humrep/17.5.1249]
20. Gleicher N, Kim A, Michaeli T, Lee HJ, Shohat-Tal A, Lazzaroni E, et al. A pilot cohort study of granulocyte colony-stimulating factor in the treatment of unresponsive thin endometrium resistant to standard therapies. Hum Reprod 2013; 28: 172-177. [DOI:10.1093/humrep/des370]
21. Eftekhar M, Sayadi M, Arabjahvani F. Transvaginal perfusion of G-CSF for infertile women with thin endometrium in frozen ET program: A non-randomized clinical trial. Iran J Reprod Med 2014; 12: 661-666.
22. Aleyasin A, Aghahosseini M, Mohseni M, Mahdavi A. Effects of pentoxifylline and vitamin E on pregnancy rate in infertile women treated by ZIFT: a randomized clinical trial. Iran J Reprod Med 2009; 7: 175-179.
23. Eftekhar M, Rahmani E, Eftekhar T. Effect of adding human chorionic gonadotropin to the endometrial preparation protocol in frozen embryo transfer cycles. Int J Fertil Steril 2012; 6: 175-178.
24. Schumacher A, Brachwitz N, Sohr S, Engeland K, Langwisch S, Dolaptchieva M. Human chorionic gonadotropin attracts regulatory T cells into the fetal-maternal; interface during early human pregnancy. J Immunol. 2009; 182: 5488-5497. [DOI:10.4049/jimmunol.0803177]
25. Sher G, Fisch JD. Vaginal sildenafil (Viagra): a preliminary report of a novel method to improve uterine artery blood flow and endometrial development in patients undergoing IVF. Hum Reprod 2000; 15: 806-809. [DOI:10.1093/humrep/15.4.806]
26. Check JH, Graziano V, Lee G, Nazari A, Choe JK, Dietterich C. Neither sildenafil nor vaginal estradiol improves endometrial thickness in women with thin endometria after taking oral estradiol in graduating dosages. Clin Exp Obstet Gynecol 2004; 31: 99-102.
27. Acharya S, Yasmin E, Balen AH. The use of a combination of pentoxifylline and tocopherol in women with a thin endometrium undergoing assisted conception therapies-a report of 20 cases. Hum Fertil 2009; 12: 198-203. [DOI:10.3109/14647270903377178]
28. Ziebe S, Loft A, Povlsen BB, Erb K, Agerholm I, Aasted M, et al. A randomized clinical trial to evaluate the effect of granulocyte-macrophage colony-stimulating factor (GM-CSF) in embryo culture medium for in vitro fertilization. Fertil Steril 2013; 99: 1600-1609. [DOI:10.1016/j.fertnstert.2012.12.043]
29. Balaban B, Urman B. Effect of oocyte morphology on embryo development and implantation. Reprod Biomed 2006; 12: 608-615. [DOI:10.1016/S1472-6483(10)61187-X]
30. Margalioth EJ, Ben-Chetrit A, Gal M, Eldar-Geva T. Investigation and treatment of repeated implantation failure following IVF-ET. Hum Reprod 2006; 21: 3036-3043. [DOI:10.1093/humrep/del305]
31. Tesarik J, Hazout A, Mendoza C. Luteinizing hormone affects uterine receptivity independently of ovarian function. Reprod Biomed Online 2003; 7: 59-64. [DOI:10.1016/S1472-6483(10)61729-4]
32. Thurin A, Hardarson T, Hausken J, Jablonowska B, Lundin K, Pinborg A. Predictors of ongoing implantation in IVF in a good prognosis group of patients. Hum Reprod 2005; 20: 1876-1880. [DOI:10.1093/humrep/deh872]
33. Santiba-ez A, García J, Pashkova O, Colín O, Castellanos G, Sánchez A, et al. Effect of intrauterine injection of human chorionic gonadotropin before embryo transfer on clinical pregnancy rates from in vitro fertilization cycles: a prospective study. Reprod Biolo Endocrinol 2014; 12: 9. [DOI:10.1186/1477-7827-12-9]
34. Papanikolaou E, Kyrou D, Zervakakou G, Paggou E, Humaidan P. Follicular HCG endometrium priming for IVF patients experiencing resisting thin endometrium. A proof of concept study. J Assist Reprod Genet 2013; 30: 1341-1345. [DOI:10.1007/s10815-013-0076-0]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
